[Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer]
- PMID: 18751708
- DOI: 10.1007/s00292-008-1034-y
[Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer]
Abstract
Germ line inactivation of the von-Hippel-Lindau (VHL) tumor suppressor gene causes von Hippel-Lindau hereditary cancer syndrome, and somatic mutations of this gene have been linked to the development of sporadic hemangioblastomas and clear cell renal carcinomas. The protein encoded by VHL, pVHL, has no known enzymatic activities but interacts with various partner proteins. In this review, various pVHL functions are highlighted. pVHL acts as a multi-purpose adaptor protein that controls different gene expression programs. Through its oxygen-dependent regulation of hypoxia-inducible factor alpha (HIFalpha), pVHL plays a central role in the oxygen-sensing pathway. In addition, many HIFalpha-independent functions of pVHL have recently been identified. These include microtubule-based processes, extracellular matrix assembly and suppression of kidney cyst formation. These complex pVHL functions can explain the diverse consequences of pVHL dysregulation in tumor formation and progression.
Similar articles
-
Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.Cancer Res. 2002 Jul 1;62(13):3803-11. Cancer Res. 2002. PMID: 12097293
-
The von Hippel-Lindau tumor suppressor gene and kidney cancer.Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6290S-5S. doi: 10.1158/1078-0432.CCR-sup-040025. Clin Cancer Res. 2004. PMID: 15448019 Review.
-
Role of VHL gene mutation in human cancer.J Clin Oncol. 2004 Dec 15;22(24):4991-5004. doi: 10.1200/JCO.2004.05.061. J Clin Oncol. 2004. PMID: 15611513 Review.
-
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.Hum Mol Genet. 2001 May 1;10(10):1019-27. doi: 10.1093/hmg/10.10.1019. Hum Mol Genet. 2001. PMID: 11331612
-
Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor.Oncogene. 2011 Jan 6;30(1):21-31. doi: 10.1038/onc.2010.395. Epub 2010 Aug 30. Oncogene. 2011. PMID: 20802534 Free PMC article.
Cited by
-
Hypoxia-regulated lncRNA CRPAT4 promotes cell migration via regulating AVL9 in clear cell renal cell carcinomas.Onco Targets Ther. 2018 Aug 3;11:4537-4545. doi: 10.2147/OTT.S169155. eCollection 2018. Onco Targets Ther. 2018. PMID: 30122945 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical